C

CJ Bioscience Inc
KOSDAQ:311690

Watchlist Manager
CJ Bioscience Inc
KOSDAQ:311690
Watchlist
Price: 9 300 KRW 0.54% Market Closed
Market Cap: 121.6B KRW
Section:
 

Relative Value

The Relative Value of one CJ Bioscience Inc stock under the Base Case scenario is 598.59 KRW. Compared to the current market price of 9 300 KRW, CJ Bioscience Inc is Overvalued by 94%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
598.59 KRW
Overvaluation 94%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

35.9
P/S
P/S
Price to Sales
35.9
vs History
46
vs Industry
5
Median 3Y
35.4
Median 5Y
35.2
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-5.5
Industry
22.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-6.8
Industry
14.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-4.2
Industry
21.5
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
85
vs Industry
28
Median 3Y
2
Median 5Y
2.7
Industry
2.2
More Details
19.8
EV/S
EV/S
Enterprise Value to Sales
19.8
vs History
68
vs Industry
5
Median 3Y
19.7
Median 5Y
24
Industry
2.6
More Details
156.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
156.9
vs History
20
vs Industry
1
Median 3Y
110.9
Median 5Y
91.9
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-4
Industry
11.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-3.6
Industry
16.9
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-3
Median 5Y
-5.6
Industry
14.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-4.4
Industry
18.7
More Details
3.2
EV/IC
EV/IC
Enterprise Value to IC
3.2
vs History
63
vs Industry
18
Median 3Y
3.2
Median 5Y
3.4
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
CJ Bioscience Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
CJ Bioscience Inc
KOSDAQ:311690
121.5B KRW 35.9 -4 -2.4 -2.1
US
Veeva Systems Inc
NYSE:VEEV
39.8B USD 12.9 46.2 35.7 37.2
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
26B AUD 117.9 225.8 156.2 156.2
JP
M3 Inc
TSE:2413
1.5T JPY 4.9 36.8 18.5 22.1
US
Doximity Inc
NYSE:DOCS
8.6B USD 13.9 34.1 30 31.4
US
Waystar Holding Corp
NASDAQ:WAY
6B USD 5.8 54 17.8 27.9
SE
Sectra AB
STO:SECT B
52.9B SEK 24.8 90.3 -127.1 -127.1
US
Inspire Medical Systems Inc
NYSE:INSP
4B USD 4.5 89.2 74 99.4
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
282.2B INR 10.6 58.1 36.1 42.2
US
Vocera Communications Inc
F:V00
2.4B EUR 11.9 -328.9 268.6 4 300.7
P/E Multiple
Earnings Growth PEG
KR
C
CJ Bioscience Inc
KOSDAQ:311690
Average P/E: 76.4
Negative Multiple: -4 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
46.2
32%
1.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
225.8
32%
7.1
JP
M3 Inc
TSE:2413
36.8
16%
2.3
US
Doximity Inc
NYSE:DOCS
34.1
18%
1.9
US
W
Waystar Holding Corp
NASDAQ:WAY
54
N/A N/A
SE
Sectra AB
STO:SECT B
90.3
28%
3.2
US
Inspire Medical Systems Inc
NYSE:INSP
89.2
13%
6.9
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
58.1
30%
1.9
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
C
CJ Bioscience Inc
KOSDAQ:311690
Average EV/EBITDA: 73.2
Negative Multiple: -2.4 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
35.7
39%
0.9
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
156.2
32%
4.9
JP
M3 Inc
TSE:2413
18.5
14%
1.3
US
Doximity Inc
NYSE:DOCS
30
23%
1.3
US
W
Waystar Holding Corp
NASDAQ:WAY
17.8
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -127.1 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
74
80%
0.9
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
36.1
24%
1.5
US
V
Vocera Communications Inc
F:V00
268.6
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
C
CJ Bioscience Inc
KOSDAQ:311690
Average EV/EBIT: 528.9
Negative Multiple: -2.1 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
37.2
39%
1
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
156.2
31%
5
JP
M3 Inc
TSE:2413
22.1
N/A N/A
US
Doximity Inc
NYSE:DOCS
31.4
25%
1.3
US
W
Waystar Holding Corp
NASDAQ:WAY
27.9
56%
0.5
SE
Sectra AB
STO:SECT B
Negative Multiple: -127.1 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
99.4
34%
2.9
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
42.2
27%
1.6
US
V
Vocera Communications Inc
F:V00
4 300.7
N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.